Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans
Open accessAbstract
The pathogenic fungus Cryptococcus neoformans infects humans upon inhalation and causes the most common fungal meningoencephalitis in immunocompromised subjects worldwide. In the host, C. neoformans is found both intracellularly and extracellularly, but how these two components contribute to the development of the disease is largely unknown. Here we show that the glycosphingolipid glucosylceramide (GlcCer), which is present in C. neoformans, was essential for fungal growth in host extracellular environments, such as in alveolar spaces and in the bloodstream, which are characterized by a neutral/alkaline pH, but not in the host intracellular environment, such as in the phagolysosome of macrophages, which is characteristically acidic. Indeed, a C. neoformans mutant strain lacking GlcCer did not grow in vitro at a neutral/alkaline pH, yet it had no growth defect at an acidic pH. The mechanism by which GlcCer regulates alkali tolerance was by allowing the transition of C. neoformans through the cell cycle. This study establishes C. neoformans GlcCer as a key virulence factor of cryptococcal pathogenicity, with important implications for future development of new antifungal strategies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
APX001, alone or in combination with fluconazole, significantly decreased the fungal burden in both the lungs and the brain in a mouse model of cryptococcal infection.
“APX001, alone or in combination with fluconazole, significantly decreased the fungal burden in both the lungs and the brain in a mouse model of cryptococcal infection98.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 47 · Cited by 239
Research works printed but not linked: 1
- Villee, C.A. 1957. Biology. Saunders. Philadelphia, Pennsylvania, USA. 615 pp.
- Authors
- Rittershaus, P. C.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Rittershaus, P. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1651-1659
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1466548
- OpenAlex
- W1966404042
- Cited by
- 239
- References
- 47
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 8 · 2021: 20 · 2020: 21 · 2019: 10 · 2018: 11 · 2017: 7 · 2016: 18 · 2015: 17 · 2014: 11 · 2013: 7 · 2012: 7
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- SMARTech Repository (Georgia Institute of Technology) (submittedVersion)
- Funders
- National Science Foundation (0132573)
- National Institutes of Health (1c06rr015455-01a1, GM-069338)
- National Institute of General Medical Sciences (U54GM069338, GM 069338)
- National Institute of Allergy and Infectious Diseases (AI56168, R01AI056168)
- National Center for Research Resources (P20RR017677, RR 17677, C06 RR-015455)
- Office of Experimental Program to Stimulate Competitive Research (EPS-0132573)
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- Cryptococcus neoformans, glucosylceramide, glucosylceramide synthase, fungal pathogenicity, virulence factors, glycosphingolipids, alkaline tolerance, cell cycle, phagolysosomes, macrophages, bloodstream infection, antifungal drug targets
- MeSH terms
- Animals, Cell Cycle, Cryptococcus neoformans, Fungal Proteins, Glucosyltransferases, Humans, Hydrogen-Ion Concentration, Lung, Mice, Inbred CBA, Survival Rate, Virulence Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review